TEVA logo

TEVA Cost of goods sold

annual cost of goods sold:

$8.48B+$281.00M(+3.43%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TEVA annual cost of goods sold is $8.48 billion, with the most recent change of +$281.00 million (+3.43%) on December 31, 2024.
  • During the last 3 years, TEVA annual cost of goods sold has risen by +$197.00 million (+2.38%).
  • TEVA annual cost of goods sold is now -24.53% below its all-time high of $11.24 billion, reached on December 31, 2017.

Performance

TEVA Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly cost of goods sold:

$2.12B+$103.20M(+5.12%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA quarterly cost of goods sold is $2.12 billion, with the most recent change of +$103.20 million (+5.12%) on June 30, 2025.
  • Over the past year, TEVA quarterly cost of goods sold has dropped by -$22.80 million (-1.07%).
  • TEVA quarterly cost of goods sold is now -32.29% below its all-time high of $3.13 billion, reached on December 31, 2017.

Performance

TEVA quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM cost of goods sold:

$8.42B-$22.80M(-0.27%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA TTM cost of goods sold is $8.42 billion, with the most recent change of -$22.80 million (-0.27%) on June 30, 2025.
  • Over the past year, TEVA TTM cost of goods sold has increased by +$195.20 million (+2.37%).
  • TEVA TTM cost of goods sold is now -28.43% below its all-time high of $11.77 billion, reached on December 31, 2017.

Performance

TEVA TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

TEVA Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.4%-1.1%+2.4%
3 y3 years+2.4%+5.2%+3.4%
5 y5 years-9.3%+0.5%-8.1%

TEVA Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6.7%-3.0%+9.9%-0.7%+5.9%
5 y5-year-9.3%+6.7%-12.0%+9.9%-8.1%+5.9%
alltimeall time-24.5%>+9999.0%-32.3%+1236.6%-28.4%+4840.3%

TEVA Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.12B(+5.1%)
$8.42B(-0.3%)
Mar 2025
-
$2.01B(-4.5%)
$8.45B(-0.4%)
Dec 2024
$8.48B(+3.4%)
$2.11B(-3.4%)
$8.48B(+0.8%)
Sep 2024
-
$2.18B(+2.0%)
$8.41B(+2.2%)
Jun 2024
-
$2.14B(+4.5%)
$8.23B(+0.7%)
Mar 2024
-
$2.05B(+0.3%)
$8.17B(-0.4%)
Dec 2023
$8.20B(+3.1%)
$2.04B(+2.1%)
$8.20B(-0.9%)
Sep 2023
-
$2.00B(-4.0%)
$8.27B(+0.9%)
Jun 2023
-
$2.08B(+0.1%)
$8.20B(+0.8%)
Mar 2023
-
$2.08B(-1.6%)
$8.13B(+1.7%)
Dec 2022
$7.95B(-4.0%)
$2.11B(+9.7%)
$8.00B(+0.5%)
Sep 2022
-
$1.93B(-4.3%)
$7.96B(-2.3%)
Jun 2022
-
$2.01B(+3.6%)
$8.15B(-0.3%)
Mar 2022
-
$1.94B(-6.3%)
$8.17B(-2.2%)
Dec 2021
$8.28B(-7.3%)
$2.07B(-2.1%)
$8.36B(-3.8%)
Sep 2021
-
$2.12B(+3.9%)
$8.69B(-0.1%)
Jun 2021
-
$2.04B(-4.4%)
$8.70B(-0.8%)
Mar 2021
-
$2.13B(-11.4%)
$8.77B(-1.8%)
Dec 2020
$8.93B(-4.5%)
$2.40B(+13.1%)
$8.93B(-1.2%)
Sep 2020
-
$2.13B(+0.9%)
$9.03B(-1.5%)
Jun 2020
-
$2.11B(-8.0%)
$9.17B(-1.9%)
Mar 2020
-
$2.29B(-8.8%)
$9.35B(-0.0%)
Dec 2019
$9.35B(-6.3%)
$2.51B(+10.9%)
$9.35B(+0.7%)
Sep 2019
-
$2.26B(-0.9%)
$9.29B(-2.6%)
Jun 2019
-
$2.28B(-0.4%)
$9.53B(-3.9%)
Mar 2019
-
$2.29B(-6.3%)
$9.92B(-4.4%)
Dec 2018
$9.97B(-11.2%)
$2.45B(-2.4%)
$10.37B(-6.2%)
Sep 2018
-
$2.51B(-6.0%)
$11.05B(-4.0%)
Jun 2018
-
$2.67B(-3.0%)
$11.51B(-1.7%)
Mar 2018
-
$2.75B(-12.1%)
$11.71B(-0.5%)
Dec 2017
$11.24B(+9.6%)
$3.13B(+5.4%)
$11.77B(+0.2%)
Sep 2017
-
$2.97B(+3.6%)
$11.74B(+1.8%)
Jun 2017
-
$2.87B(+1.9%)
$11.54B(+6.5%)
Mar 2017
-
$2.81B(-9.4%)
$10.84B(+7.9%)
Dec 2016
$10.25B(+23.6%)
$3.10B(+12.3%)
$10.04B(+11.9%)
Sep 2016
-
$2.76B(+27.8%)
$8.98B(+8.6%)
Jun 2016
-
$2.16B(+7.0%)
$8.27B(+1.2%)
Mar 2016
-
$2.02B(-0.7%)
$8.17B(-1.5%)
Dec 2015
$8.30B(-10.0%)
$2.03B(-0.9%)
$8.30B(-2.9%)
Sep 2015
-
$2.05B(-0.6%)
$8.54B(-2.3%)
Jun 2015
-
$2.06B(-3.8%)
$8.74B(-3.5%)
Mar 2015
-
$2.15B(-5.8%)
$9.06B(-1.7%)
Dec 2014
$9.22B(-4.1%)
$2.28B(+1.3%)
$9.22B(-3.3%)
Sep 2014
-
$2.25B(-5.7%)
$9.53B(-2.6%)
Jun 2014
-
$2.38B(+3.5%)
$9.79B(-0.5%)
Mar 2014
-
$2.30B(-11.3%)
$9.83B(-0.8%)
Dec 2013
$9.61B(-0.6%)
$2.60B(+3.8%)
$9.91B(+1.4%)
Sep 2013
-
$2.50B(+3.0%)
$9.78B(+2.4%)
Jun 2013
-
$2.43B(+2.0%)
$9.55B(+1.7%)
Mar 2013
-
$2.38B(-3.3%)
$9.39B(-0.0%)
Dec 2012
$9.66B(+9.9%)
$2.46B(+8.2%)
$9.40B(-2.2%)
Sep 2012
-
$2.28B(+0.1%)
$9.61B(+2.0%)
Jun 2012
-
$2.27B(-4.6%)
$9.41B(+2.0%)
Mar 2012
-
$2.38B(-10.7%)
$9.23B(+5.1%)
Dec 2011
$8.80B(+24.7%)
$2.67B(+28.2%)
$8.78B(+8.9%)
Sep 2011
-
$2.08B(-0.3%)
$8.06B(+4.2%)
Jun 2011
-
$2.09B(+8.1%)
$7.74B(+5.4%)
Mar 2011
-
$1.93B(-1.0%)
$7.34B(+4.2%)
Dec 2010
$7.06B
$1.95B(+11.1%)
$7.05B(+3.1%)
DateAnnualQuarterlyTTM
Sep 2010
-
$1.76B(+3.7%)
$6.83B(+2.3%)
Jun 2010
-
$1.70B(+3.4%)
$6.68B(+1.4%)
Mar 2010
-
$1.64B(-6.0%)
$6.59B(+0.5%)
Dec 2009
$6.53B(+27.7%)
$1.74B(+8.6%)
$6.56B(+8.0%)
Sep 2009
-
$1.60B(+0.0%)
$6.07B(+4.2%)
Jun 2009
-
$1.60B(-0.1%)
$5.83B(+5.8%)
Mar 2009
-
$1.61B(+27.5%)
$5.51B(+8.1%)
Dec 2008
$5.12B(+12.9%)
$1.26B(-7.4%)
$5.10B(+0.3%)
Sep 2008
-
$1.36B(+5.7%)
$5.08B(+5.1%)
Jun 2008
-
$1.29B(+8.0%)
$4.84B(+2.2%)
Mar 2008
-
$1.19B(-4.2%)
$4.73B(+3.3%)
Dec 2007
$4.53B(+9.2%)
$1.24B(+11.8%)
$4.58B(+1.6%)
Sep 2007
-
$1.11B(-5.8%)
$4.51B(+2.2%)
Jun 2007
-
$1.18B(+13.5%)
$4.41B(+4.4%)
Mar 2007
-
$1.04B(-11.0%)
$4.22B(+2.2%)
Dec 2006
$4.15B(+49.8%)
$1.17B(+15.2%)
$4.13B(+12.8%)
Sep 2006
-
$1.02B(+2.1%)
$3.66B(+10.0%)
Jun 2006
-
$995.39M(+4.7%)
$3.33B(+11.7%)
Mar 2006
-
$950.69M(+35.5%)
$2.98B(+8.6%)
Dec 2005
$2.77B(+8.2%)
$701.44M(+2.7%)
$2.75B(-0.7%)
Sep 2005
-
$683.12M(+5.5%)
$2.77B(+1.0%)
Jun 2005
-
$647.50M(-9.5%)
$2.74B(+1.2%)
Mar 2005
-
$715.61M(-0.6%)
$2.71B(+5.7%)
Dec 2004
$2.56B(+45.7%)
$719.97M(+9.7%)
$2.56B(+8.6%)
Sep 2004
-
$656.59M(+7.0%)
$2.36B(+9.5%)
Jun 2004
-
$613.74M(+7.5%)
$2.15B(+9.9%)
Mar 2004
-
$570.72M(+10.2%)
$1.96B(+9.3%)
Dec 2003
$1.76B(+23.5%)
$517.68M(+14.7%)
$1.79B(+5.0%)
Sep 2003
-
$451.22M(+7.5%)
$1.71B(+6.0%)
Jun 2003
-
$419.65M(+3.7%)
$1.61B(+8.0%)
Mar 2003
-
$404.51M(-6.5%)
$1.49B(+7.0%)
Dec 2002
$1.42B(+15.7%)
$432.54M(+22.2%)
$1.39B(+8.2%)
Sep 2002
-
$354.08M(+17.7%)
$1.29B(+4.9%)
Jun 2002
-
$300.83M(-1.9%)
$1.23B(-0.4%)
Mar 2002
-
$306.60M(-6.3%)
$1.23B(+1.3%)
Dec 2001
$1.23B(+27.7%)
$327.18M(+11.3%)
$1.22B(+9.9%)
Sep 2001
-
$293.92M(-3.7%)
$1.11B(+2.2%)
Jun 2001
-
$305.19M(+4.8%)
$1.08B(+5.3%)
Mar 2001
-
$291.12M(+33.7%)
$1.03B(+9.7%)
Dec 2000
$962.99M(+37.7%)
$217.80M(-19.3%)
$938.37M(+30.2%)
Sep 2000
-
$269.72M(+7.4%)
$720.57M(+59.8%)
Jun 2000
-
$251.10M(+25.7%)
$450.85M(+125.7%)
Mar 2000
-
$199.75M(+7.4%)
$199.75M(-61.2%)
Dec 1999
$699.20M(+9.9%)
-
-
Dec 1998
$636.10M(+1.1%)
-
-
Sep 1998
-
$186.00M(+17.4%)
$514.90M(+56.6%)
Jun 1998
-
$158.40M(-7.1%)
$328.90M(+92.9%)
Mar 1998
-
$170.50M
$170.50M
Dec 1997
$628.90M(+14.3%)
-
-
Dec 1996
$550.40M(+14.3%)
-
-
Dec 1995
$481.50M(+15.7%)
-
-
Dec 1994
$416.20M(+55.0%)
-
-
Dec 1993
$268.50M(+20.0%)
-
-
Dec 1992
$223.80M(+15.3%)
-
-
Dec 1991
$194.10M(+1.5%)
-
-
Dec 1990
$191.30M(+5.9%)
-
-
Dec 1989
$180.70M(+39.5%)
-
-
Dec 1988
$129.50M(+52.5%)
-
-
Mar 1987
$84.90M(+44.4%)
-
-
Mar 1986
$58.80M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cost of goods sold?

The current annual cost of goods sold of TEVA is $8.48B

What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cost of goods sold is $11.24B

What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?

Over the past year, TEVA annual cost of goods sold has changed by +$281.00M (+3.43%)

What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?

The current quarterly cost of goods sold of TEVA is $2.12B

What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cost of goods sold is $3.13B

What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?

Over the past year, TEVA quarterly cost of goods sold has changed by -$22.80M (-1.07%)

What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?

The current TTM cost of goods sold of TEVA is $8.42B

What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cost of goods sold is $11.77B

What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?

Over the past year, TEVA TTM cost of goods sold has changed by +$195.20M (+2.37%)
On this page